As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
We have now added a new section called the "Assay History List" to the "At A Gla...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...